Pharmena SA

Pharmena SA - public biotechnology company, the core business of which is the development and commercialization of innovative products derived from patented physiological and natural active substance 1-MNA. It carries out projects in the areas of clinical research on innovative antiatherogenic drug, production of innovative dermo-cosmetics and implementation of an innovative dietary supplement used to meet the specific nutritional needs in the prevention of atherosclerosis.

Since 2008, the Company has been listed on the NewConnect market.